Daith piercing may relieve migraines by stimulating the vagus nerve via an ear acupressure point used in traditional medicine. Anecdotal success rates range from 30–50% reporting reduced attack frequency. No large-scale randomized controlled trial has confirmed efficacy, but a 2017 BMJ Case Reports publication and 2020 survey data show meaningful subjective improvement in roughly 1 in 3 patients.
The daith is the small fold of cartilage directly above the ear canal opening, forming the innermost arch of the outer ear. In auricular acupuncture — a system developed in France by Paul Nogier in the 1950s and formalized by the World Health Organization in 1990 — this zone corresponds to a point called Master Cerebral (Point 34b) and intersects with the vagus nerve auricular branch.
The proposed mechanism: mechanical stimulation of this branch triggers a parasympathetic response, reducing cortical spreading depression — the electrical wave believed to initiate migraine aura and pain. This is the same nerve pathway targeted by non-invasive vagus nerve stimulators (nVNS) like gammaCore, an FDA-cleared device that delivers 25Hz electrical pulses to the neck at 100mA intensity.
A daith piercing creates permanent mechanical pressure at 1–2mm depth through 0.8–1.6mm titanium or surgical steel jewelry, delivering continuous low-grade stimulation to the same auricular branch that nVNS devices target transiently.
A 2017 case report in BMJ Case Reports documented a 54-year-old woman with 30-year chronic migraine history (averaging 4–6 attacks per month, each lasting 4–72 hours). Following a left-side daith piercing, she reported complete cessation of migraine attacks for 12 months post-procedure. The authors noted she had also received acupuncture at the same auricular point, complicating attribution.
A 2020 cross-sectional survey published in Regional Anesthesia and Pain Medicine collected responses from 380 self-reported migraine sufferers who had received daith piercings. Results:
No double-blind randomized controlled trial exists as of mid-2026. The core confound is that a piercing cannot be blinded — participants always know they have one. Placebo response rates in migraine trials typically run 20–35%, meaning a meaningful portion of reported improvement may be non-specific. The American Headache Society has not endorsed daith piercing as a therapeutic intervention.
| Intervention | Evidence Level | Avg Frequency Reduction | Cost (USD) | Reversible |
|---|---|---|---|---|
| Daith piercing | Case reports, surveys | 30–47% (self-reported) | $50–$120 | Yes (let close) |
| gammaCore nVNS device | FDA-cleared, RCT evidence | 30–40% responder rate | $600+/year | Yes |
| Botox (onabotulinumtoxinA) | FDA-approved (chronic migraine) | ~50% at 24 weeks | $300–$600/quarter | Yes (wears off) |
| Magnesium supplementation | Level B evidence (AHS) | ~41% (400–600mg/day) | $10–$25/month | Yes |
| Auricular acupuncture | Small RCTs, inconsistent | 25–35% | $60–$120/session | Yes |
Most practitioners recommend piercing on the same side as your dominant migraine pain. If you experience bilateral migraines without a dominant side, the left side is conventionally preferred, as left vagus nerve stimulation has more clinical literature supporting parasympathetic modulation. Of the 380 respondents in the 2020 survey, 61% chose the left side regardless of laterality, and this group showed slightly higher responder rates (51% vs. 41% for right-side piercings).
If you have unilateral migraines — for example, consistent right-temple pain — a right daith piercing is the logical starting point.
Daith cartilage healing follows a three-phase process:
If migraines do not improve within 6 months of full healing, allowing the piercing to close carries no permanent consequences — the scar tissue is minimal in cartilage at 16-gauge.
The patients most likely to report benefit in survey data share these characteristics: episodic migraine (fewer than 15 headache days per month), history of partial response to acupuncture or pressure-based therapies, and migraines with clear laterality. Those with chronic daily headache (15+ days/month) showed lower responder rates in the 2020 survey — 28% vs. 51% for episodic sufferers.
The risk-to-reward calculation is straightforward: a daith piercing at a professional studio costs $50–$120, is reversible, and carries low complication risk when performed with sterile technique and implant-grade materials. For context, a single Botox migraine treatment costs $300–$600 and must be repeated every 3 months indefinitely.
At Multnomah Piercing, daith piercings are performed with implant-grade titanium jewelry, single-use sterile needles, and thorough aftercare consultation — the same standard you'd find at APP-member studios anywhere in the country. Proper placement and jewelry selection are the two variables most correlated with both healing success and reported migraine outcomes in survey data; a poorly placed daith in cheap jewelry is not the same intervention as a correctly placed one in quality metal.
If you're exploring daith piercing as part of your migraine management strategy, book a consultation at multnomahpiercing.io — walk through your anatomy, your migraine pattern, and which side makes sense for your specific situation before committing to the procedure.